Measuring Breast Cancer Cell Growth with Flow Cytometry
Author Information
Author(s): Y. Remvikos, P. Vielh, E. Padoy, B. Benyahia, N. Voillemot, H. Magdelenat
Primary Institution: Institut Curie
Hypothesis
Can the proliferative activity of breast cancer cells be accurately measured using flow cytometry on cytological samples?
Conclusion
The study successfully demonstrates that the proliferative activity of breast tumors can be routinely estimated using S-phase fractions and BrdU labeling index from fine needle sampling.
Supporting Evidence
- Proliferative activity is an important predictor of clinical outcomes in breast cancer.
- SPF and BLI were obtained from the same sample in 94 cases, showing a strong correlation.
- At least one quantitative proliferation index could be obtained for 91% of patients.
Takeaway
Doctors can check how fast breast cancer cells are growing by taking a tiny sample of the tumor and using special tests.
Methodology
The study involved fine needle sampling of tumor cells from 189 patients, followed by flow cytometry to measure S-phase fractions and BrdU labeling index.
Potential Biases
Potential bias due to the selection of samples for analysis based on cell count.
Limitations
Some samples were non-informative due to insufficient cell numbers or poor quality histograms.
Participant Demographics
Patients with breast cancer, specific demographics not detailed.
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.0001
Want to read the original?
Access the complete publication on the publisher's website